Status:
COMPLETED
COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Hvidovre University Hospital
Region Hovedstadens Apotek
Conditions:
SARS-CoV Infection
Covid19
Eligibility:
All Genders
16-120 years
Phase:
NA
Brief Summary
The aim of this study is to compare the SARS-CoV-2 detection rate using either a Saliva, oropharyngeal swabs or nasopharyngeal swab method for specimen collection.
Detailed Description
The reference test to evaluate patients with suspected respiratory infection caused by virus is a real-time reverse transcription-polymerase chain reaction (RT-PCR) from a nasopharyngeal swab (NPS). H...
Eligibility Criteria
Inclusion
- volunteers, who are attending the COVID-19 test facilities to obtain a RT-PCR test.
- oral and written informed consent to participate before entering the study.
Exclusion
- Failure to understand and provide informed consent.
- Neck breathers (tracheostomy/laryngectomy patients) or other nasopharyngeal or oropharyngeal anomalies that do not allow for sampling using swabs.
Key Trial Info
Start Date :
January 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
27947 Patients enrolled
Trial Details
Trial ID
NCT04715607
Start Date
January 22 2021
End Date
May 31 2021
Last Update
September 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Valby COVID-19 teststed
Copenhagen, Valby, Denmark, 2500